Public consultation on applications to be considered by the MSAC (March/April 2022)

Overview

Consultation is now open for applications that are anticipated to be considered by the Medical Services Advisory Committee (MSAC) on 31 March - 1 April 2022.

MSAC values consultation input from individuals and organisations with an interest in an application that it is considering, including experience of the medical conditions, services or technologies being addressed by the application.   

It is anticipated that the below-mentioned applications will proceed to MSAC in March/April 2022. Consultation input must be received by no later than Friday, 11 February 2022 for it to be considered by MSAC. A consultation survey form is available on the relevant application webpage.

Further information on MSAC’s consultation process is also available on the MSAC website.

Applications scheduled to be considered:

Resubmissions:

1354.1 – Intravascular ultrasound guided coronary stent insertion

1614.1 - Magnetic resonance-guided focused ultrasound for the treatment of medically refractory essential tremor

New applications:

1613 – Permanent acute coronary syndrome event detector (insertion, removal or replacement of) for monitoring of the heart's electrical activity

1646 – Whole genome sequencing of antimicrobial-resistant pathogens

1669 – KRAS G12C variant testing to determine eligibility for PBS-subsidised sotorasib second-line therapy in patients with locally advanced or metastatic non-small cell lung cancer

1673 – Single operator, single use, peroral cholangiopancreatoscopy for diagnosis of indeterminate biliary strictures and removal of difficult biliary stones

1678 - Integrating practice pharmacists into Aboriginal Community Controlled Health Services (The IPAC Project)

1679 - Improved medication management for Aboriginal and Torres Strait Islanders Feasibility Study (IMeRSe Feasibility Study)

1695 – Procedures for the implantation and refill-exchange of the Port Delivery System with ranibizumab to treat neovascular age-related macular degeneration

1699 - National Lung Cancer Screening Program

1709 – Somatic gene testing for the diagnosis of glioma, including glioblastoma

What happens next

Once the consultation closes, submissions will be compiled and considered by MSAC.

Once it has finalised its appraisal of an application for public funding, MSAC publishes a Public Summary Document (PSD). The PSD captures MSAC deliberations and key advice to the Minister, which is generally to either support funding; not support funding; or defer consideration. 

PSDs are generally published approximately three (3) months after the MSAC meeting at which the application was considered. The PSD can be located on the relevant application webpage on the MSAC website.